Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.

Chun-Pai YangCheng-Chieh LinChia-Ing LiChiu-Shong LiuChih-Hsueh LinKai-Lin HwangShing-Yu YangTsai-Chung Li

Published in: Cardiovascular diabetology (2020)

The associations between HbA1c, variability in FPG-CV, and PAD suggest a linked pathophysiological mechanism, suggesting the crucial role of glycemic variability in clinical management and therapeutic goals in preventing PAD in type 2 diabetes.

Keyphrases

type diabetes
peripheral artery disease
glycemic control
blood glucose
insulin resistance
cardiovascular disease
metabolic syndrome
public health